Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Early implementation of treatment with biologic or targeted synthetic DMARDs after methotrexate failure did not prevent the ...

Changes in the make-up of the gut microbiome are linked to the onset of clinically evident rheumatoid arthritis in those at ...

According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

Despite experiencing joint pain—especially in her hands—along with body aches, hot flushes and sleeplessness, Richardson dismissed these symptoms as "normal," until one day in June when she was unable ...

Rheumatoid arthritis is a chronic autoimmune disease that affects mainly the joints and sometimes other organs. Though its exact cause remains unclear, the onset of rheumatoid arthritis is ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.

“In people who may develop [rheumatoid arthritis], these antibodies can appear in the blood long before any symptoms, like joint pain or stiffness, become noticeable. Essentially, the presence ...